
Surgery Partners (SGRY) Stock Forecast & Price Target
Surgery Partners (SGRY) Analyst Ratings
Bulls say
Surgery Partners is well positioned for long-term growth and earnings potential, supported by strong leadership, a diverse and talented workforce, and a strategic focus on high-acuity procedures. The recent divestiture of its Idaho Falls market removes a key overhang and allows the company to focus on its core business of ambulatory surgical centers. The company's targeted growth strategy, impressive track record with physician recruitment, and disciplined approach to M&A present attractive opportunities for future growth. While there may be risks related to reimbursement rates and labor costs, the company's efficient operating model and strong management should help mitigate these factors.
Bears say
Surgery Partners is struggling to maintain sustainability due to concerns surrounding both workforce diversity and environmental impact. Despite taking steps to address COVID-19 safety measures, the pandemic has also significantly impacted the company's financials, with lower volumes and higher debt. Their valuation may also be negatively impacted by their mix of mature and emerging healthcare providers in their portfolio, as well as potential market corrections and recessions.
This aggregate rating is based on analysts' research of Surgery Partners and is not a guaranteed prediction by Public.com or investment advice.
Surgery Partners (SGRY) Analyst Forecast & Price Prediction
Start investing in Surgery Partners (SGRY)
Order type
Buy in
Order amount
Est. shares
0 shares